{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:20:40Z","timestamp":1785522040563,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["AEC 2020\/007\\u201311"],"award-info":[{"award-number":["AEC 2020\/007\\u201311"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG-1907-34571"],"award-info":[{"award-number":["RG-1907-34571"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","award":["SCR_013672"],"award-info":[{"award-number":["SCR_013672"]}],"id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neuroscience.2024.08.030","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T20:11:39Z","timestamp":1724357499000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration model"],"prefix":"10.1016","volume":"559","author":[{"given":"Gabriella E.","family":"Parrilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshana","family":"Vander Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Chitranshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaraj","family":"Basavarajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.08.030_b0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.clinph.2014.11.010","article-title":"Multifocal VEP assessment of optic neuritis evolution","volume":"126","author":"Alshowaeir","year":"2015","journal-title":"Clin. Neurophysiol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-150029","article-title":"The continuing failure of bexarotene in Alzheimer's disease mice","volume":"46","author":"Balducci","year":"2015","journal-title":"J. Alzheimers. Dis"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jnnp.45.2.143","article-title":"Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes","volume":"45","author":"Beatty","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exer.2016.01.014","article-title":"Glial coverage in the optic nerve expands in proportion to optic axon loss in chronic mouse glaucoma","volume":"150","author":"Bosco","year":"2016","journal-title":"Exp. Eye. Res"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fnagi.2018.00430","article-title":"Age related decline in cortical multifocal flash VEP: latency increases shown to be predominately magnocellular","volume":"10","author":"Brown","year":"2018","journal-title":"Front. Aging. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"Brown","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuroscience.2024.08.030_b0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.25007","article-title":"Dose-dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis","volume":"100","author":"Castoldi","year":"2022","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0040","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"Cordano","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0045","doi-asserted-by":"crossref","unstructured":"Crowley, L. C., Waterhouse, N. J. (2016). Detecting Cleaved Caspase-3 in Apoptotic Cells by Flow Cytometry. Cold Spring Harb Protoc, 2016.","DOI":"10.1101\/pdb.prot087312"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbalip.2011.09.014","article-title":"The retinoid X receptors and their ligands","volume":"1821","author":"Dawson","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0009-9120(91)90421-A","article-title":"Central nervous system myelin: structure, function, and pathology","volume":"24","author":"Deber","year":"1991","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0060","first-page":"355","article-title":"Visual recovery following optic nerve crush in male and female wild-type and TRIF-deficient mice","volume":"38","author":"Du","year":"2020","journal-title":"Restor. Neurol. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-021-01131-8","article-title":"Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain","volume":"9","author":"Ferreira","year":"2021","journal-title":"Acta. Neuropathol. Commun"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01621459.1937.10503522","article-title":"The use of ranks to avoid the assumption of normality implicit in the analysis of variance","volume":"32","author":"Friedman","year":"1937","journal-title":"j. Am. Statistical Associat."},{"key":"10.1016\/j.neuroscience.2024.08.030_b0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.24030","article-title":"Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis","volume":"75","author":"Gabilondo","year":"2014","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0080","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113462","article-title":"Bexarotene promotes microglia\/macrophages - Specific brain - Derived Neurotrophic factor expression and axon sprouting after traumatic brain injury","volume":"334","author":"He","year":"2020","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang","year":"2011","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105421","article-title":"Retinoid X receptor-mediated neuroprotection via CYP19 upregulation and subsequent increases in estradiol synthesis","volume":"193","author":"Ishihara","year":"2019","journal-title":"J. Steroid. Biochem. Mol. Biol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153461","article-title":"Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro","volume":"487","author":"Kubickova","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNO.0000000000000704","article-title":"Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis","volume":"38","author":"Leocani","year":"2018","journal-title":"J. Neuroophthalmol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109011","article-title":"An optimized procedure to record visual evoked potential in mice","volume":"218","author":"Liu","year":"2022","journal-title":"Exp. Eye. Res"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.820155","article-title":"Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes","volume":"16","author":"Marenna","year":"2022","journal-title":"Front. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0120","doi-asserted-by":"crossref","first-page":"42270","DOI":"10.1038\/srep42270","article-title":"Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease","volume":"7","author":"Mariani","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0125","doi-asserted-by":"crossref","first-page":"e0223578","DOI":"10.1371\/journal.pone.0223578","article-title":"Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer s disease","volume":"14","author":"Munoz-Cabrera","year":"2019","journal-title":"PLoS. One"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.26529","article-title":"Trans-Synaptic Degeneration Following Acute Optic Neuritis in Multiple Sclerosis","volume":"93","author":"Murphy","year":"2022","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0135","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","article-title":"Myelination and support of axonal integrity by glia","volume":"468","author":"Nave","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/revneuro-2023-0081","article-title":"The role of myelin in neurodegeneration: implications for drug targets and neuroprotection strategies","volume":"35","author":"Parrilla","year":"2024","journal-title":"Rev. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0169-328X(98)00311-8","article-title":"Stimulation of the myelin basic protein gene expression by 9-cis-retinoic acid and thyroid hormone: activation in the context of its native promoter","volume":"64","author":"Pombo","year":"1999","journal-title":"Brain. Res. Mol. Brain. Res"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0150","doi-asserted-by":"crossref","first-page":"e1005213","DOI":"10.1371\/journal.pgen.1005213","article-title":"9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice","volume":"11","author":"Ruhl","year":"2015","journal-title":"PLoS. Genet"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0155","article-title":"Bexarotene drives the self-renewing proliferation of adult neural stem cells, promotes neuron-glial fate shift, and regulates late neuronal differentiation","author":"Saibro-Girardi","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2024.08.030_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135764","article-title":"Retinoid X receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease","volume":"750","author":"Santos-Gil","year":"2021","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0165","series-title":"Fundamental Statistical Principles for the Neurobiologist","first-page":"157","article-title":"Nonparametric Statistics","author":"Scheff","year":"2016"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0170","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.survophthal.2021.06.001","article-title":"Trans-synaptic degeneration in the visual pathway: Neural connectivity, pathophysiology, and clinical implications in neurodegenerative disorders","volume":"67","author":"Sharma","year":"2022","journal-title":"Surv. Ophthalmol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0180","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1210\/en.2005-0706","article-title":"Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis","volume":"147","author":"Sharma","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0185","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO. J"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2015.12.003","article-title":"Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1","volume":"277","author":"Tachibana","year":"2016","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12031-016-0790-z","article-title":"Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models","volume":"60","author":"Wagenknecht","year":"2016","journal-title":"J. Mol. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0200","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.biopsych.2010.12.017","article-title":"Retinoid x receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice","volume":"69","author":"Wietrzych-Schindler","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/acupmed-2016-011134","article-title":"Effects of electroacupuncture and the retinoid X receptor (RXR) signalling pathway on oligodendrocyte differentiation in the demyelinated spinal cord of rats","volume":"35","author":"Yang","year":"2017","journal-title":"Acupunct. Med"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0210","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends. Neurosci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0215","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1167\/iovs.11-7434","article-title":"Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis","volume":"52","author":"You","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1016\/j.neuroscience.2024.08.030_b0220","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awy338","article-title":"Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease","volume":"142","author":"You","year":"2019","journal-title":"Brain"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224004299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224004299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T05:30:22Z","timestamp":1734327022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224004299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":44,"alternative-id":["S0306452224004299"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.030","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration model","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}